UTERINE CARCINOSARCOMA
Clinical trials for UTERINE CARCINOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new UTERINE CARCINOSARCOMA trials appear
Sign up with your email to follow new studies for UTERINE CARCINOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill shows promise in battling Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new oral drug, VLS-1488, in people with advanced solid tumors that have not responded to other treatments. The goal is to find a safe dose and see if it can shrink tumors or slow cancer growth. About 200 adults with specific cancers like ovarian, lung, or breas…
Matched conditions: UTERINE CARCINOSARCOMA
Phase: PHASE1, PHASE2 • Sponsor: Volastra Therapeutics, Inc. • Aim: Disease control
Last updated May 17, 2026 05:29 UTC
-
New pill shows promise in early trial for Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage study tests a new oral drug, NKT5097, in 205 adults with advanced solid tumors that have not responded to other treatments. The main goals are to find the safest dose and understand side effects. The study focuses on breast cancer and other tumors with specific g…
Matched conditions: UTERINE CARCINOSARCOMA
Phase: PHASE1 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated May 12, 2026 13:39 UTC